^
Association details:
Evidence:
Evidence Level:
Sensitive: C3 – Early Trials
New
Title:

Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket Study

Excerpt:
Three patients had PRs to vismodegib (unknown primary cancer, n = 1; squamous skin cancer, n = 1; salivary gland cancer, n = 1); all three patients had PTCH-1–mutated tumors.
DOI:
10.1200/JCO.2017.75.3780
Trial ID: